Clinical Trials Directory

Trials / Completed

CompletedNCT05118061

StatStrip Glucose/Ketone Meter System Ketone Evaluation

Status
Completed
Phase
Study type
Observational
Enrollment
173 (actual)
Sponsor
Nova Biomedical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The Nova StatStrip Glucose / Ketone Meter System is a fast, simple, whole blood system that can be used to quantify both glucose and ketones using two distinct test strips. This Protocol will describe an evaluation of the system's Ketone performance only. Ketone testing methods that quantify beta-hydroxybutyrate (β-OHB), the predominant ketone body, are used for diagnosing and monitoring ketoacidosis, a life-threatening complication of hyperglycemia. The performance of the StatStrip Ketone test strip using the Nova StatStrip Glucose / Ketone Hospital Meter System on venous and capillary whole blood will be assessed.

Detailed description

The primary objectives of this study are: 1. To assess the performance of the StatStrip Ketone assay in the hands of CLIA-Waived Point-of-Care users in at least three (3) distinct Point-of-Care clinical settings on venous, and capillary blood and compare the performance characteristics to a traceable laboratory reference method. 2. To assess the Ease of Use of the StatStrip Glucose / Ketone Meter System in the hands of the intended CLIA-Waived Point-of-Care users. CLIA-Waived operators will be provided with all package-insert sheets, a Quick Reference Guide and Instructions for Use (IFU) Manual. No training, coaching, or prompting will be provided to the CLIA-Waived POC Users other than clarifying the protocol.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTKetonecompare diagnostic tests to reference methods

Timeline

Start date
2022-05-25
Primary completion
2022-08-03
Completion
2022-08-03
First posted
2021-11-11
Last updated
2022-09-30

Locations

3 sites across 2 countries: United States, Germany

Regulatory

Source: ClinicalTrials.gov record NCT05118061. Inclusion in this directory is not an endorsement.